STRATEGY STUDIO / NONPROFIT PEOPLE SEARCH

LUPUS RESEARCH ALLIANCE INC: Form 990, tax year 2021

View the entire original 990 at ProPublica ↗

Organization
LUPUS RESEARCH ALLIANCE INC (EIN 58-2492929)
Tax period
2021-01-01 to 2021-12-31
Filed
2022-09-14
IRS object ID
202232579349301913
Schema version
2021v4.2
Source
Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header ReturnHeader

FieldValueIRS element (for citing)
Return2022-09-14T14:17:17-05:00ReturnTs
Tax Period End2021-12-31TaxPeriodEndDt

Preparer Firm PreparerFirmGrp

FieldValueIRS element (for citing)
Preparer Firm EIN131655065PreparerFirmEIN

Preparer Firm Name PreparerFirmName

FieldValueIRS element (for citing)
Business Name Line1LUTZ AND CARR CPAS LLPBusinessNameLine1Txt

Preparer US Address PreparerUSAddress

FieldValueIRS element (for citing)
Address Line1551 FIFTH AVENUE SUITE 400AddressLine1Txt
CityNEW YORKCityNm
State AbbreviationNYStateAbbreviationCd
ZIP10176ZIPCd
FieldValueIRS element (for citing)
Return Type990ReturnTypeCd
Tax Period Begin2021-01-01TaxPeriodBeginDt

Filer Filer

FieldValueIRS element (for citing)
EIN582492929EIN

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1LUPUS RESEARCH ALLIANCE INCBusinessNameLine1Txt
FieldValueIRS element (for citing)
Business Name ControlLUPUBusinessNameControlTxt
Phone2122182840PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line1270 MADISON AVENUE SUITE 300AddressLine1Txt
CityNEW YORKCityNm
State AbbreviationNYStateAbbreviationCd
ZIP10016ZIPCd

Business Officer BusinessOfficerGrp

FieldValueIRS element (for citing)
PersonDEBRA ROSEPersonNm
Person TitleCHIEF FIN. AND ADMIN. OFFICERPersonTitleTxt
Phone2122182840PhoneNum
Signature2022-09-14SignatureDt
Discuss With Paid PreparerYes (1)DiscussWithPaidPreparerInd

Signing Officer SigningOfficerGrp

Person Full Name PersonFullName

FieldValueIRS element (for citing)
Person FirstDEBRAPersonFirstNm
Person LastROSEPersonLastNm
FieldValueIRS element (for citing)
SSN999009999SSN

Preparer Person PreparerPersonGrp

FieldValueIRS element (for citing)
Preparer PersonLAUREN CRESCIPreparerPersonNm
PTINP01268493PTIN
Phone2126972299PhoneNum

Additional Filer Information AdditionalFilerInformation

Trusted Customer TrustedCustomerGrp

FieldValueIRS element (for citing)
Trusted Customer3TrustedCustomerCd
Authentication Assurance LevelAAL1AuthenticationAssuranceLevelCd
Identity Assurance LevelIAL1IdentityAssuranceLevelCd
FieldValueIRS element (for citing)
Tax2021TaxYr
Build TS2023-04-26 12:10:37ZBuildTS

Form 990 IRS990

FieldValueIRS element (for citing)
Address ChangeYes (X)AddressChangeInd
Principal OfficerKENNETH M FARBERPrincipalOfficerNm

US Address USAddress

FieldValueIRS element (for citing)
Address Line1270 MADISON AVENUE SUITE 300AddressLine1Txt
CityNEW YORKCityNm
State AbbreviationNYStateAbbreviationCd
ZIP10016ZIPCd
FieldValueIRS element (for citing)
Gross Receipts$29,599,200GrossReceiptsAmt
Group Return For Affiliates0GroupReturnForAffiliatesInd
Organization501c3Yes (X)Organization501c3Ind
Website AddressLUPUSRESEARCH.ORGWebsiteAddressTxt
Type Of Organization CorpYes (X)TypeOfOrganizationCorpInd
Formation1999FormationYr
Legal Domicile StateNYLegalDomicileStateCd
Activity Or MissionTO SUPPORT RESEARCH TO PREVENT, TREAT AND CURE LUPUS.ActivityOrMissionDesc
Voting Members Governing Body26VotingMembersGoverningBodyCnt
Voting Members Independent26VotingMembersIndependentCnt
Total Employee59TotalEmployeeCnt
Total Volunteers500TotalVolunteersCnt
Total Gross UBI$0TotalGrossUBIAmt
Net Unrelated Bus Txbl Incm$0NetUnrelatedBusTxblIncmAmt
PY Contributions Grants$41,539,746PYContributionsGrantsAmt
CY Contributions Grants$18,941,837CYContributionsGrantsAmt
PY Program Service Revenue$1,291,193PYProgramServiceRevenueAmt
CY Program Service Revenue$1,036,685CYProgramServiceRevenueAmt
PY Investment Income$1,938,994PYInvestmentIncomeAmt
CY Investment Income$3,679,888CYInvestmentIncomeAmt
PY Other Revenue$20,119PYOtherRevenueAmt
CY Other Revenue$121,620CYOtherRevenueAmt
PY Total Revenue$44,790,052PYTotalRevenueAmt
CY Total Revenue$23,780,030CYTotalRevenueAmt
PY Grants And Similar Paid$23,030,250PYGrantsAndSimilarPaidAmt
CY Grants And Similar Paid$15,031,432CYGrantsAndSimilarPaidAmt
PY Benefits Paid To Members$0PYBenefitsPaidToMembersAmt
CY Benefits Paid To Members$0CYBenefitsPaidToMembersAmt
PY Salaries Comp Emp Bnft Paid$5,962,910PYSalariesCompEmpBnftPaidAmt
CY Salaries Comp Emp Bnft Paid$6,237,294CYSalariesCompEmpBnftPaidAmt
PY Total Prof Fndrsng Expns$49,000PYTotalProfFndrsngExpnsAmt
CY Total Prof Fndrsng Expns$65,000CYTotalProfFndrsngExpnsAmt
CY Total Fundraising Expense$2,778,881CYTotalFundraisingExpenseAmt
PY Other Expenses$5,224,653PYOtherExpensesAmt
CY Other Expenses$5,438,357CYOtherExpensesAmt
PY Total Expenses$34,266,813PYTotalExpensesAmt
CY Total Expenses$26,772,083CYTotalExpensesAmt
PY Revenues Less Expenses$10,523,239PYRevenuesLessExpensesAmt
CY Revenues Less Expenses-$2,992,053CYRevenuesLessExpensesAmt
Total Assets BOY$103,408,141TotalAssetsBOYAmt
Total Assets EOY$110,909,946TotalAssetsEOYAmt
Total Liabilities BOY$41,851,086TotalLiabilitiesBOYAmt
Total Liabilities EOY$41,423,828TotalLiabilitiesEOYAmt
Net Assets Or Fund Balances BOY$61,557,055NetAssetsOrFundBalancesBOYAmt
Net Assets Or Fund Balances EOY$69,486,118NetAssetsOrFundBalancesEOYAmt
Info In Schedule O Part IIIYes (X)InfoInScheduleOPartIIIInd
MissionTHE LUPUS RESEARCH ALLIANCE LEADS THE WORLD IN TRANSFORMING THE LIVES OF PEOPLE AFFECTED WITH LUPUS BY USING THE POWER OF SCIENCE TO DRIVE NEW TREATMENTS, PREVENT DISEASE PROGRESSION, AND FIND A CURE.MissionDesc
Significant New Program Srvc0SignificantNewProgramSrvcInd
Significant Change0SignificantChangeInd
Expense$11,722,856ExpenseAmt
Grant$10,660,064GrantAmt
DescRESEARCH:THE LUPUS RESEARCH ALLIANCE (LRA) IS THE LARGEST NON-GOVERNMENTAL, NON-PROFIT FUNDER OF LUPUS RESEARCH WORLDWIDE. THE ORGANIZATION AIMS TO TRANSFORM TREATMENT BY FUNDING THE MOST INNOVATIVE LUPUS RESEARCH, FOSTERING DIVERSE SCIENTIFIC TALENT, AND DRIVING DISCOVERY TOWARD BETTER DIAGNOSTICS AND IMPROVED TREATMENTS. LRA-FUNDED RESEARCH IS LEADING TO KEY DISCOVERIES THAT ARE IMPROVING DIAGNOSIS AND THERAPIES WHILE ADVANCING TOWARD PREVENTION AND ULTIMATELY A CURE. THE ORGANIZATION'S RESEARCH COMMITTEE OF THE BOARD OF DIRECTORS AND SCIENTIFIC ADVISORY BOARD INCLUDE TOP SCIENTIFIC EXPERTS, AND KEY LAY MEMBERS OF THE BOARD, WHO WORK WITH STAFF TO STRATEGICALLY GUIDE AND DRIVE THE RESEARCH FUNDING AGENDA. SINCE ITS INCEPTION, THE LRA HAS COMMITTED OVER $220 MILLION TO FUND LUPUS RESEARCH PROJECTS. IN 2021 ALONE, OVER $10,600,000 MILLION WAS AWARDED IN GRANTS FOR HIGHLY INNOVATIVE PROJECTS WITH THE POTENTIAL TO IMPROVE TREATMENT AS WELL AS UNDERSTAND THE CAUSES OF LUPUS AND THUS LEAD TO A CURE: 1) 2 GLOBAL TEAM SCIENCE AWARDS WERE AWARDED FOR $3 MILLION FOR A TOTAL OF $6 MILLION OVER TWO YEARS. THESE AWARDS WILL FUND MULTIDISCIPLINARY, COLLABORATIVE AND HIGHLY SYNERGISTIC PROJECTS THAT PUSH THE BOUNDARIES OF INNOVATION AND BRIDGE RESEARCH AND CLINICAL EFFORTS IN LUPUS. THE TEAMS WILL FOCUS ON UNRAVELING HUMAN LUPUS HETEROGENEITY WITH THE AIM TO DISCOVER NEW AVENUES TO PERSONAL TREATMENT APPROACHES; 2) 11 LUPUS INNOVATION AWARD GRANTS WERE AWARDED FOR A TOTAL OF $3.3 MILLION OVER TWO YEARS FOCUSING ON EARLY-STAGE FUNDAMENTAL RESEARCH INTO DISEASE MECHANISMS; 3) 7 ADMINISTRATIVE DIVERSITY SUPPLEMENT TO PROMOTED DIVERSITY IN LUPUS RESEARCH WERE AWARDED TOTALING APPROXIMATELY $150,000. THESE AWARDS FUND HIGHLY QUALIFIED AND PROMISING UNDERREPRESENTED MINORITY TRAINEES TO SUPPORT THEIR RESEARCH EXPERIENCES ALIGNED WITH AN LRA PARENT AWARD. 4) THE DISTINGUISHED INNOVATOR AWARD PROGRAM PROVIDES OUTSTANDING SCIENTISTS WITH SUBSTANTIAL SUPPORT TO CONDUCT HIGHLY INNOVATIVE RESEARCH TO UNCOVER THE UNDERLYING CAUSES OF LUPUS, A SUPPLEMENTAL $500,000 WAS AWARDED OVER TWO YEARS TO A CURRENTLY FUNDED RESEARCHER TO CONTINUED PROPOSED WORK. 5) THE LUPUS INSIGHT PRIZE WAS AWARDED FOR $100,000. THIS AWARD RECOGNIZES A LEADING RESEARCHER WHO HAS MADE A MAJOR CONTRIBUTION TO THE FIELD.6) LRA IS PROVIDING $100,000 PER YEAR TO THE FOUNDATION FOR THE NATIONAL INSTITUTES OF HEALTH IN SUPPORT OF THE ACCELERATING MEDICINES PARTNERSHIP (AMP) AUTOIMMUNITY AND IMMUNE-MEDIATED (AIM) DISEASES PROGRAM WHICH LEVERAGES DATA GENERATED BY THE PREVIOUS WORK DONE ON LUPUS BY THIS PROGRAM.THE LRA'S UNIQUE FUNDING MODEL SUPPORTS PROMISING RESEARCH EFFORTS WITH THE GOAL OF IMPROVING THE LIVES OF PEOPLE WITH LUPUS IN THE NEAR FUTURE. THROUGH A COMPETITIVE PEER-REVIEW PROCESS PROJECTS BY THE LRA AIM TO TRANSLATE RESULTS FROM THE RESEARCH BENCH TO THE BEDSIDE AS QUICKLY AS POSSIBLE. BECAUSE THE LUPUS RESEARCH ALLIANCE BOARD OF DIRECTORS FUNDS THE ADMINISTRATIVE AND FUNDRAISING EXPENSES, 100% OF ALL OTHER CONTRIBUTIONS GOES TO SUPPORT THE LRA'S LUPUS RESEARCH PROGRAMS.Desc

Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp

FieldValueIRS element (for citing)
Expense$9,253,814ExpenseAmt
Grant$4,359,632GrantAmt
Revenue$1,036,685RevenueAmt
DescSCIENTIFIC PROGRAMS:LUPUS RESEARCH ALLIANCE'S (LRA) SCIENTIFIC PROGRAM CONTINUED THEIR MOMENTUM IN 2021 EVEN WITH THE ONGOING PANDEMIC. THE IMPLEMENTATION OF LRA'S SCIENTIFIC STRATEGIC PLAN FOCUSING ON HETEROGENEITY CONTINUED WITH MUCH WORK DONE IN SEVERAL FRONTS. THE LRA ENCOURAGES CROSS-SECTOR AND CROSS-DISCIPLINE PARTNERSHIPS TO FOSTER THE MOST INNOVATIVE AND PRODUCTIVE RESEARCH ENVIRONMENT. IN 2021, VIRTUAL COLLABORATIVE MEETINGS WERE HELD BY THE LRA WHERE RESEARCHERS WERE ENCOURAGED TO EXCHANGE IDEAS AND HELP THE LRA CONTINUE SUCCESSFUL PROGRAMS WHILE TARGETING NEW RESEARCH OPPORTUNITIES. THIS INCLUDED THE: ANNUAL FORUM FOR DISCOVERY WHERE LRA-FUNDED SCIENTISTS AND GUESTS SHARE THEIR PROGRESS; RESEARCH COMMITTEE MEETINGS WHERE MEMBERS OF OUR BOARD OF DIRECTORS AS WELL AS TOP-LEVEL RESEARCHERS DISCUSSED OUR PORTFOLIO AND UPCOMING STRATEGIC STEPS; SCIENTIFIC ADVISORY BOARD MEETINGS WHERE HIGHLY REGARDED SCIENTIFIC ADVISORS REVIEW GRANT APPLICATION SUBMISSIONS AND DISCUSS FUTURE AND OVERALL RESEARCH STRATEGY FOR THE ORGANIZATION; LUPUS INDUSTRY FULL COUNCIL AND EXECUTIVE COMMITTEE MEETINGS WHERE THE LRA AND INDUSTRY REPRESENTATIVES FOCUSED ON SOLVING SHARED OBSTACLES TO CLINICAL TRIALS; CONTINUED MEETINGS WITH INDUSTRY AND OTHER DISEASE -FOCUSED NONPROFIT PARTNERS AS PART OF THE LRA ACCELERATOR AWARD PROGRAM AND COMMON MECHANISMS IN AUTOIMMUNITY GRANT PROGRAMS; CLINICAL TRIALS AWARENESS FAIRS THAT ENGAGE THE LUPUS COMMUNITY IN UNDERSTANDING, PARTICIPATING IN AND ADVOCATING FOR LUPUS CLINICAL TRIALS; AND LUPUS CLINICAL INVESTIGATORS NETWORK (LUCIN) MEETINGS WHERE TOP RESEARCHERS DISCUSS THE DESIGN AND PROGRESS FOR LUPUS CLINICAL TRIALS. THE LRA FOUNDED LUPUS THERAPEUTICS, LLC AS AN AFFILIATE OF THE LRA IN 2018 TO RUN LUCIN TO ADVANCE CLINICAL TRIALS AND FACILITATE THE DEVELOPMENT OF MUCH NEEDED NEW LUPUS TREATMENTS. THE LRA COMMITTED OVER $4.3 MILLION IN 1-YEAR GRANTS IN 2021 TO CONTINUE FUNDING THRU 2023 OF TOP ACADEMIC CENTERS TO FOSTER CLINICAL TRIAL PARTICIPATION IN LUCIN. LUPUS THERAPEUTICS (LT) CONTINUES TO HAVE A DIVERSE PORTFOLIO OF ONGOING CLINICAL TRIALS WITHIN LUCIN AND AS OF 2021, THERE HAVE BEEN TWENTY STUDIES MANAGED VIA LUPUS THERAPEUTICS IN CONJUNCTION WITH THE LUCIN NETWORK WITH AN EMPHASIS ON NEW TREATMENTS FOR LUPUS IN PHASE II AND III CLINICAL STUDIES. POSITIVE RESULTS WERE REPORTED ON TWO STUDIES WITH 4 MORE STUDIES RESULTS EXPECTED IN 2022. MOREOVER, LT HAS A HEALTHY PIPELINE OF NEW BUSINESS DEVELOPMENT DISCUSSIONS WITH INDUSTRY RELATED TO PERFORMING ADVISORY SERVICES AND/OR CONDUCTING PROSPECTIVE CLINICAL TRIALS WITHIN THE NETWORK AND COMPLETED 9 CONSULTATIVE ENGAGEMENTS WITH PHARMA IN 2021. DURING 2020, THE LRA DEVELOPED A BUSINESS PLAN FOR LUPUS NEXUS, A PATIENT REGISTRY AND BIOREPOSITORY COUPLED WITH DATA SHARING AND ANALYSIS PLATFORM, TO PROVIDE A GAME-CHANGING CONTRIBUTION TO LUPUS PATIENT-CENTERED RESEARCH. WORKING WITH LUPUS THERAPEUTICS, LUPUS NEXUS WILL CAPITALIZE ON CURRENT STRATEGIC OPPORTUNITIES IN THE LUPUS FIELD BY ENABLING A COLLABORATIVE, DATA-DRIVEN PLATFORM FOR THE RESEARCH COMMUNITY. THE VISION FOR THE LUPUS NEXUS IS TO TRANSFORM LUPUS RESEARCH AND DRUG DEVELOPMENT THROUGH UNPRECEDENTED INFORMATION EXCHANGE CAPABILITIES. THE PLATFORM WILL PROVIDE A COLLABORATIVE SOLUTION THAT IS INCLUSIVE OF DIVERSE PATIENT POPULATIONS DISPROPORTIONALLY AFFECTED BY LUPUS. THE LUPUS NEXUS WILL BE A SOURCE OF HIGHLY CURATED DATA TO CATALYZE GLOBAL COLLABORATION, RESEARCH INNOVATION, AND PRECISION MEDICINE APPROACHES TO ACCELERATE LUPUS RESEARCH AND DRUG DEVELOPMENT.Desc

Prog Srvc Accom Acty3 ProgSrvcAccomActy3Grp

FieldValueIRS element (for citing)
Expense$647,293ExpenseAmt
Grant$11,736GrantAmt
DescPUBLIC POLICY:THE MAIN GOALS OF THE LUPUS RESEARCH ALLIANCE PUBLIC POLICY PROGRAM ARE TO: EDUCATE MEMBERS OF CONGRESS ABOUT ISSUES OF PRIORITY TO THE LUPUS COMMUNITY; INCREASE FEDERAL FUNDING FOR LUPUS RESEARCH BY INCREASING OVERALL NATIONAL INSTITUTES OF HEALTH (NIH) FUNDS, AND SECURE ADDITIONAL FUNDING FOR LUPUS RESEARCH THROUGH OTHER KEY FEDERAL AGENCIES INCLUDING THE DEPARTMENT OF DEFENSE (DOD); AND ENSURE THE PATIENT VOICE IS INCORPORATED IN THE DRUG DEVELOPMENT PROCESS. VOLUNTEERS ACROSS THE COUNTRY HELP AMPLIFY THESE OUTREACH EFFORTS.THROUGH THE LUPUS RESEARCH ALLIANCE ONGOING PUBLIC POLICY PROGRAM EFFORTS, SIGNIFICANT FUNDING FOR LUPUS RESEARCH HAS BEEN OBTAINED UNDER THE DEPARTMENT OF DEFENSE (DOD) CONGRESSIONALLY DIRECTED MEDICAL RESEARCH PROGRAMS (CDMRP) OPERATED BY THE ARMY MEDICAL RESEARCH AND MATERIEL COMMAND. FIRST, THE LUPUS RESEARCH ALLIANCE WAS RESPONSIBLE FOR PERSUADING CONGRESS TO INCLUDE LUPUS IN ITS LIST OF DESIGNATED DISEASES ELIGIBLE FOR FUNDING IN THE PEER REVIEWED MEDICAL PROGRAM. MOST RECENTLY, LUPUS RESEARCH ALLIANCE ADVOCACY SUCCEEDED IN THE ESTABLISHMENT IN 2017 OF THE LUPUS RESEARCH PROGRAM UNDER THE CDMRP. OVER THE PROGRAM'S FIRST THREE YEARS, $5 MILLION WAS EARMARKED EACH YEAR SPECIFICALLY FOR LUPUS; THROUGH THE LUPUS RESEARCH ALLIANCE'S CONTINUED EFFORTS THIS AMOUNT WAS INCREASED TO $10M IN FISCAL YEARS (FY) 2020, 2021, AND 2022 DEFENSE APPROPRIATIONS BILLS OVER SIX YEARS, $45M WAS SECURED UNDER THIS PROGRAM, AND THE LRA HAS REQUESTED AN INCREASE TO $15M FOR FY 2023.THE LRA COLLABORATED WITH THE LUPUS AND ALLIED DISEASES ASSOCIATION (LADA) AND LUPUS FOUNDATION OF AMERICA (LFA) IN 2017 ON THE LUPUS PATIENT-FOCUSED DRUG DEVELOPMENT (PFDD) INITIATIVE. THIS EFFORT CULMINATED IN A REPORT THAT WAS DESIGNED TO PROVIDE THE FOOD AND DRUG ADMINISTRATION (FDA) WITH PERSPECTIVES FROM PEOPLE WITH LUPUS, ADVOCATES, AND CAREGIVERS TO HELP INFORM THE FDA'S DECISIONS AND OVERSIGHT DURING THE DRUG DEVELOPMENT AND REVIEW PROCESSES. THE LRA CONTINUES TO WORK TO BRING THE VOICE OF THE PATIENT TO THE DRUG REVIEW PROCESS BY RESPONDING TO RELEVANT CALLS FROM THE FDA FOR COMMENTS INCLUDING THOSE FOCUSED ON ENSURING CLINICAL TRIAL PARTICIPANTS REPRESENT THE REAL-WORLD DEMOGRAPHIC CHARACTERISTICS OF PEOPLE LIVING WITH THE DISEASEONGOING ADVOCACY FOCUSES ON ENSURING LEGISLATION THAT SECURES THE FEDERAL FUNDING SUPPORT NECESSARY TO AFFORD INVESTIGATORS THE RESOURCES TO FOLLOW THROUGH WITH RESEARCH DISCOVERIES THAT WILL IMPROVE TREATMENT OF LUPUS. EVERY YEAR, THE LRA TRAINS AND ORGANIZES ADVOCATES FROM ACROSS THE COUNTRY TO MEET WITH LEGISLATORS ON CAPITOL HILL. THE GOAL IS TO INCREASE AWARENESS OF LUPUS AND THE IMPACT IT HAS ON PEOPLES' DAILY LIVES TO MEMBERS OF CONGRESS AND TO REQUEST THEIR SUPPORT FOR INCREASED FUNDING FOR LUPUS RESEARCH FROM FEDERAL PROGRAMS SUCH AS THE NIH.Desc
FieldValueIRS element (for citing)
Total Program Service Expenses$21,623,963TotalProgramServiceExpensesAmt
Described In Section501c3Yes (1)DescribedInSection501c3Ind
Schedule B RequiredYes (1)ScheduleBRequiredInd
Political Campaign Acty0PoliticalCampaignActyInd
Lobbying ActivitiesYes (1)LobbyingActivitiesInd
Subject To Proxy Tax0SubjectToProxyTaxInd
Donor Advised Fund0DonorAdvisedFundInd
Conservation Easements0ConservationEasementsInd
Collections Of Art0CollectionsOfArtInd
Credit Counseling0CreditCounselingInd
Donor Rstr Or Quasi EndowmentsYes (1)DonorRstrOrQuasiEndowmentsInd
Report Land Building EquipmentYes (1)ReportLandBuildingEquipmentInd
Report Investments Other Sec0ReportInvestmentsOtherSecInd
Report Program Related Invst0ReportProgramRelatedInvstInd
Report Other Assets0ReportOtherAssetsInd
Report Other LiabilitiesYes (1)ReportOtherLiabilitiesInd
Include FIN48 Footnote0IncludeFIN48FootnoteInd
Independent Audit Fincl Stmt0IndependentAuditFinclStmtInd
Consolidated Audit Fincl StmtYes (1)ConsolidatedAuditFinclStmtInd
School Operating0SchoolOperatingInd
Foreign Office0ForeignOfficeInd
Foreign ActivitiesYes (1)ForeignActivitiesInd
More Than5000 K To OrgYes (1)MoreThan5000KToOrgInd
More Than5000 K To Individuals0MoreThan5000KToIndividualsInd
Professional FundraisingYes (1)ProfessionalFundraisingInd
Fundraising ActivitiesYes (1)FundraisingActivitiesInd
Gaming Activities0GamingActivitiesInd
Operate Hospital0OperateHospitalInd
Grants To OrganizationsYes (1)GrantsToOrganizationsInd
Grants To IndividualsYes (1)GrantsToIndividualsInd
Schedule J RequiredYes (1)ScheduleJRequiredInd
Tax Exempt Bonds0TaxExemptBondsInd
Engaged In Excess Benefit Trans0EngagedInExcessBenefitTransInd
PY Excess Benefit Trans0PYExcessBenefitTransInd
Loan Outstanding0LoanOutstandingInd
Grant To Related Person0GrantToRelatedPersonInd
Business Rln With Org Mem0BusinessRlnWithOrgMemInd
Business Rln With Fam Mem0BusinessRlnWithFamMemInd
Business Rln With35 Ctrl Ent0BusinessRlnWith35CtrlEntInd
Deductible Non Cash ContriYes (1)DeductibleNonCashContriInd
Deductible Art Contribution0DeductibleArtContributionInd
Terminate Operations0TerminateOperationsInd
Partial Liquidation0PartialLiquidationInd
Disregarded EntityYes (1)DisregardedEntityInd
Related Entity0RelatedEntityInd
Related Organization Ctrl Ent0RelatedOrganizationCtrlEntInd
Trnsfr Exmpt Non Chrtbl Rltd Org0TrnsfrExmptNonChrtblRltdOrgInd
Activities Conducted Prtshp0ActivitiesConductedPrtshpInd
Schedule O RequiredYes (1)ScheduleORequiredInd
IRP Document74IRPDocumentCnt
IRP Document W2 G0IRPDocumentW2GCnt
Backup Wthld ComplianceYes (1)BackupWthldComplianceInd
Employee59EmployeeCnt
Employment Tax Returns FiledYes (1)EmploymentTaxReturnsFiledInd
Unrelated Bus Incm Over Limit0UnrelatedBusIncmOverLimitInd
Foreign Financial Account0ForeignFinancialAccountInd
Prohibited Tax Shelter Trans0ProhibitedTaxShelterTransInd
Taxable Party Notification0TaxablePartyNotificationInd
Nondeductible Contributions0NondeductibleContributionsInd
Quid Pro Quo ContributionsYes (1)QuidProQuoContributionsInd
Quid Pro Quo Contri DisclYes (1)QuidProQuoContriDisclInd
Form8282 Property Disposed Of0Form8282PropertyDisposedOfInd
Rcv Fnds To Pay Prsnl Bnft Cntrct0RcvFndsToPayPrsnlBnftCntrctInd
Pay Premiums Prsnl Bnft Cntrct0PayPremiumsPrsnlBnftCntrctInd
Indoor Tanning Services0IndoorTanningServicesInd
Subj To Tax Rmnrtn Ex Prcht Pymt0SubjToTaxRmnrtnExPrchtPymtInd
Subject To Excs Tax Net Invst Inc0SubjectToExcsTaxNetInvstIncInd
Info In Schedule O Part VIYes (X)InfoInScheduleOPartVIInd
Governing Body Voting Members26GoverningBodyVotingMembersCnt
Independent Voting Member26IndependentVotingMemberCnt
Family Or Business RlnYes (1)FamilyOrBusinessRlnInd
Delegation Of Mgmt Duties0DelegationOfMgmtDutiesInd
Change To Org Documents0ChangeToOrgDocumentsInd
Material Diversion Or Misuse0MaterialDiversionOrMisuseInd
Members Or Stockholders0MembersOrStockholdersInd
Election Of Board Members0ElectionOfBoardMembersInd
Decisions Subject To Approva0DecisionsSubjectToApprovaInd
Minutes Of Governing BodyYes (1)MinutesOfGoverningBodyInd
Minutes Of CommitteesYes (1)MinutesOfCommitteesInd
Officer Mailing Address0OfficerMailingAddressInd
Local Chapters0LocalChaptersInd
Form990 Provided To Gvrn BodyYes (1)Form990ProvidedToGvrnBodyInd
Conflict Of Interest PolicyYes (1)ConflictOfInterestPolicyInd
Annual Disclosure Covered PrsnYes (1)AnnualDisclosureCoveredPrsnInd
Regular Monitoring EnfrcYes (1)RegularMonitoringEnfrcInd
Whistleblower PolicyYes (1)WhistleblowerPolicyInd
Document Retention PolicyYes (1)DocumentRetentionPolicyInd
Compensation Process CEOYes (1)CompensationProcessCEOInd
Compensation Process OtherYes (1)CompensationProcessOtherInd
Investment In Joint Venture0InvestmentInJointVentureInd
States Where Copy Of Return Is FldALStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldAKStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldAZStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldARStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldCAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldCOStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldCTStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldFLStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldGAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldHIStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldILStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldKSStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldKYStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMEStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMDStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMIStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMNStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMSStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMOStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNHStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNJStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNMStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNYStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNCStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNDStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldOHStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldOKStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldORStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldPAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldRIStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldSCStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldTNStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldVAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldWAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldWVStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldWIStatesWhereCopyOfReturnIsFldCd
Own WebsiteYes (X)OwnWebsiteInd
Other WebsiteYes (X)OtherWebsiteInd
Upon RequestYes (X)UponRequestInd

Books In Care Of Detail BooksInCareOfDetail

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1DEBRA ROSEBusinessNameLine1Txt
FieldValueIRS element (for citing)
Phone6468846000PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line1270 MADISON AVE SUITE 300AddressLine1Txt
CityNEW YORKCityNm
State AbbreviationNYStateAbbreviationCd
ZIP10016ZIPCd

Form990 Part VII Section A Form990PartVIISectionAGrp (36 entries)

TitleTitleTxtAverage Hours Per WeekAverageHoursPerWeekRtIndividual Trustee Or DirectorIndividualTrusteeOrDirectorIndOfficerOfficerIndReportable Comp From OrgReportableCompFromOrgAmtReportable Comp From Rltd OrgReportableCompFromRltdOrgAmtOther CompensationOtherCompensationAmtKey EmployeeKeyEmployeeIndHighest Compensated EmployeeHighestCompensatedEmployeeInd
IRA AKSELRAD
CO-CHAIR1.00Yes (X)Yes (X)$0$0$0
RICHARD K DESCHERER
CO-CHAIR1.00Yes (X)Yes (X)$0$0$0
JOSEPH MAURIELLO
TREASURER1.00Yes (X)Yes (X)$0$0$0
BRENDA BLACKMON
SECRETARY1.00Yes (X)Yes (X)$0$0$0
BISHOP RUDY V CARLTON
DIRECTOR1.00Yes (X)$0$0$0
JEROME CHAZEN
DIRECTOR1.00Yes (X)$0$0$0
WILLIE COLON
DIRECTOR1.00Yes (X)$0$0$0
THOMAS O DANIEL
DIRECTOR1.00Yes (X)$0$0$0
JENNIE DESCHERER
DIRECTOR1.00Yes (X)$0$0$0
KATEY DRISCOLL
DIRECTOR1.00Yes (X)$0$0$0
SIR MARC FELDMANN
DIRECTOR1.00Yes (X)$0$0$0
MOTI FERDER
DIRECTOR1.00Yes (X)$0$0$0
JOE GERMANOTTA
DIRECTOR1.00Yes (X)$0$0$0
DAVID KIES
DIRECTOR1.00Yes (X)$0$0$0
DANIEL LAVECCHIA
DIRECTOR1.00Yes (X)$0$0$0
LOUIS LUCIDO
DIRECTOR1.00Yes (X)$0$0$0
VERONICA VARGAS LUPO
DIRECTOR1.00Yes (X)$0$0$0
MOLLY MCCABE
DIRECTOR1.00Yes (X)$0$0$0
NADEEM MEGHJI
DIRECTOR1.00Yes (X)$0$0$0
WILLIAM J MULVIHILL
DIRECTOR1.00Yes (X)$0$0$0
ROBERT SEDER MD
DIRECTOR1.00Yes (X)$0$0$0
DANIEL J WALLACE
DIRECTOR1.00Yes (X)$0$0$0
WILLIAM WOLFE
DIRECTOR1.00Yes (X)$0$0$0
CAROL WEISMAN
DIRECTOR1.00Yes (X)$0$0$0
JULIUS WILLIAMS
DIRECTOR1.00Yes (X)$0$0$0
SPENCER ZWICK
DIRECTOR1.00Yes (X)$0$0$0
KENNETH M FARBER
CEO AND PRESIDENT40.00Yes (X)$429,366$0$81,465
DEBRA ROSE
CHIEF FINANCE OFFICER40.00Yes (X)$220,556$0$46,478
ANDREA O'NEILL
EXECUTIVE DIRECTOR40.00$271,791$0$50,097Yes (X)
ALBERT ROY
EXECUTIVE DIRECTOR, LUCIN40.00$273,196$0$76,858Yes (X)
TEODORA STAEVA
CHIEF SCIENTIFIC OFFICER40.00$300,802$0$62,930Yes (X)
DIANE GROSS
NATIONAL DIRECTOR OF ADVOC40.00$139,784$0$42,780Yes (X)
JONATHAN MARKS
DIRECTOR OF CORPORATE DEVE40.00$143,834$0$49,003Yes (X)
MARGY MEISLIN
EDITORIAL & PR DIRECTOR40.00$133,197$0$40,693Yes (X)
PENELOPE MITCHELL
DIRECTOR OF COMMUNICATIONS40.00$172,180$0$35,785Yes (X)
DOREY NEILINGER
SENIOR DIRECTOR OF PHILANT40.00$172,399$0$35,228Yes (X)
FieldValueIRS element (for citing)
Total Reportable Comp From Org$2,257,105TotalReportableCompFromOrgAmt
Tot Reportable Comp Rltd Org$0TotReportableCompRltdOrgAmt
Total Other Compensation$521,317TotalOtherCompensationAmt
Indiv Rcvd Greater Than100 K14IndivRcvdGreaterThan100KCnt
Former Ofcr Employees Listed0FormerOfcrEmployeesListedInd
Total Comp Greater Than150 KYes (1)TotalCompGreaterThan150KInd
Compensation From Other Srcs0CompensationFromOtherSrcsInd

Contractor Compensation ContractorCompensationGrp (5 entries)

Address Line1ContractorAddress/USAddress/AddressLine1TxtCityContractorAddress/USAddress/CityNmState AbbreviationContractorAddress/USAddress/StateAbbreviationCdZIPContractorAddress/USAddress/ZIPCdServicesServicesDescCompensationCompensationAmt
CONVERGENCY LLC
1015 15TH ST 6TH FL NWWASHINGTONDC20005FDA CONSULTANT$195,000
KIM KAISER & ASSOCIATES LLC
4001 SANTA BARBARA BLVD 405NAPLESFL34104PHARMA RELATIONS CONSULTANT$185,788
EG&A CIRP DBA MCS HEALTHCARE PR
110 ALLEN RD 300BASKING RIDGENJ07921PUBLIC RELATIONS CONSULTANT$170,555
HYPATIA PROJECT LLC
1818 LIBRARY STREET SUITE 500RESTONVA20190CLINICAL OPS CONSULTANT$140,447
LAUTMAN MASKA NEIL AND CO
1703 RHODE ISLAND AVE NW STE 301WASHINGTONDC20036DIRECT RESPONSE CONSULTANTS$114,050
FieldValueIRS element (for citing)
Cntrct Rcvd Greater Than100 K5CntrctRcvdGreaterThan100KCnt
Fundraising$7,808,509FundraisingAmt
Government Grants$698,800GovernmentGrantsAmt
All Other Contributions$10,434,528AllOtherContributionsAmt
Noncash Contributions$157,755NoncashContributionsAmt
Total Contributions$18,941,837TotalContributionsAmt

Program Service Revenue ProgramServiceRevenueGrp

FieldValueIRS element (for citing)
DescLUCIN CONSULTING REVENUEDesc
Business900099BusinessCd
Total Revenue Column$1,036,685TotalRevenueColumnAmt
Related Or Exempt Func Income$1,036,685RelatedOrExemptFuncIncomeAmt
FieldValueIRS element (for citing)
Total Program Service Revenue$1,036,685TotalProgramServiceRevenueAmt

Investment Income InvestmentIncomeGrp

FieldValueIRS element (for citing)
Total Revenue Column$1,904,150TotalRevenueColumnAmt
Exclusion$1,904,150ExclusionAmt

Gross Amount Sales Assets GrossAmountSalesAssetsGrp

FieldValueIRS element (for citing)
Securities$7,003,020SecuritiesAmt

Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp

FieldValueIRS element (for citing)
Securities$5,227,282SecuritiesAmt

Gain Or Loss GainOrLossGrp

FieldValueIRS element (for citing)
Securities$1,775,738SecuritiesAmt

Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp

FieldValueIRS element (for citing)
Total Revenue Column$1,775,738TotalRevenueColumnAmt
Exclusion$1,775,738ExclusionAmt
FieldValueIRS element (for citing)
Fundraising Gross Income$591,888FundraisingGrossIncomeAmt
Contri Rpt Fundraising Event$7,808,509ContriRptFundraisingEventAmt
Fundraising Direct Expenses$591,888FundraisingDirectExpensesAmt

Net Incm From Fundraising Evt NetIncmFromFundraisingEvtGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt

Other Revenue Misc OtherRevenueMiscGrp

FieldValueIRS element (for citing)
DescSUBLET INCOMEDesc
Business900099BusinessCd
Total Revenue Column$121,620TotalRevenueColumnAmt
Exclusion$121,620ExclusionAmt
FieldValueIRS element (for citing)
Other Revenue Total$121,620OtherRevenueTotalAmt

Total Revenue TotalRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$23,780,030TotalRevenueColumnAmt
Related Or Exempt Func Income$1,036,685RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue$0UnrelatedBusinessRevenueAmt
Exclusion$3,801,508ExclusionAmt

Grants To Domestic Orgs GrantsToDomesticOrgsGrp

FieldValueIRS element (for citing)
Total$13,344,685TotalAmt
Program Services$13,344,685ProgramServicesAmt

Grants To Domestic Individuals GrantsToDomesticIndividualsGrp

FieldValueIRS element (for citing)
Total$11,736TotalAmt
Program Services$11,736ProgramServicesAmt

Foreign Grants ForeignGrantsGrp

FieldValueIRS element (for citing)
Total$1,675,011TotalAmt
Program Services$1,675,011ProgramServicesAmt

Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp

FieldValueIRS element (for citing)
Total$1,807,839TotalAmt
Program Services$965,194ProgramServicesAmt
Management And General$383,289ManagementAndGeneralAmt
Fundraising$459,356FundraisingAmt

Other Salaries And Wages OtherSalariesAndWagesGrp

FieldValueIRS element (for citing)
Total$3,148,035TotalAmt
Program Services$1,690,527ProgramServicesAmt
Management And General$631,591ManagementAndGeneralAmt
Fundraising$825,917FundraisingAmt

Pension Plan Contributions PensionPlanContributionsGrp

FieldValueIRS element (for citing)
Total$236,753TotalAmt
Program Services$128,810ProgramServicesAmt
Management And General$43,331ManagementAndGeneralAmt
Fundraising$64,612FundraisingAmt

Other Employee Benefits OtherEmployeeBenefitsGrp

FieldValueIRS element (for citing)
Total$713,482TotalAmt
Program Services$382,175ProgramServicesAmt
Management And General$145,985ManagementAndGeneralAmt
Fundraising$185,322FundraisingAmt

Payroll Taxes PayrollTaxesGrp

FieldValueIRS element (for citing)
Total$331,185TotalAmt
Program Services$177,573ProgramServicesAmt
Management And General$67,525ManagementAndGeneralAmt
Fundraising$86,087FundraisingAmt

Fees For Services Legal FeesForServicesLegalGrp

FieldValueIRS element (for citing)
Total$123,537TotalAmt
Program Services$83,842ProgramServicesAmt
Management And General$20,541ManagementAndGeneralAmt
Fundraising$19,154FundraisingAmt

Fees For Services Accounting FeesForServicesAccountingGrp

FieldValueIRS element (for citing)
Total$64,368TotalAmt
Management And General$64,368ManagementAndGeneralAmt

Fees For Services Lobbying FeesForServicesLobbyingGrp

FieldValueIRS element (for citing)
Total$190,611TotalAmt
Program Services$190,611ProgramServicesAmt

Fees For Services Prof Fundraising FeesForServicesProfFundraising

FieldValueIRS element (for citing)
Total$65,000TotalAmt
Fundraising$65,000FundraisingAmt

Fees For Srvc Invst Mgmnt Fees FeesForSrvcInvstMgmntFeesGrp

FieldValueIRS element (for citing)
Total$194,932TotalAmt
Management And General$194,932ManagementAndGeneralAmt

Fees For Services Other FeesForServicesOtherGrp

FieldValueIRS element (for citing)
Total$1,630,331TotalAmt
Program Services$1,089,335ProgramServicesAmt
Management And General$313,580ManagementAndGeneralAmt
Fundraising$227,416FundraisingAmt

Office Expenses OfficeExpensesGrp

FieldValueIRS element (for citing)
Total$92,247TotalAmt
Program Services$43,325ProgramServicesAmt
Management And General$30,862ManagementAndGeneralAmt
Fundraising$18,060FundraisingAmt

Information Technology InformationTechnologyGrp

FieldValueIRS element (for citing)
Total$411,732TotalAmt
Program Services$208,437ProgramServicesAmt
Management And General$130,957ManagementAndGeneralAmt
Fundraising$72,338FundraisingAmt

Occupancy OccupancyGrp

FieldValueIRS element (for citing)
Total$1,129,925TotalAmt
Program Services$668,328ProgramServicesAmt
Management And General$202,909ManagementAndGeneralAmt
Fundraising$258,688FundraisingAmt

Travel TravelGrp

FieldValueIRS element (for citing)
Total$46,658TotalAmt
Program Services$32,490ProgramServicesAmt
Management And General$6,603ManagementAndGeneralAmt
Fundraising$7,565FundraisingAmt

Pymt Travel Entrtnmnt Pub Ofcl PymtTravelEntrtnmntPubOfclGrp

FieldValueIRS element (for citing)
Total$362,101TotalAmt
Program Services$343,035ProgramServicesAmt
Management And General$11,092ManagementAndGeneralAmt
Fundraising$7,974FundraisingAmt

Depreciation Depletion DepreciationDepletionGrp

FieldValueIRS element (for citing)
Total$141,508TotalAmt
Program Services$75,873ProgramServicesAmt
Management And General$28,853ManagementAndGeneralAmt
Fundraising$36,782FundraisingAmt

Insurance InsuranceGrp

FieldValueIRS element (for citing)
Total$65,512TotalAmt
Program Services$41,796ProgramServicesAmt
Management And General$10,425ManagementAndGeneralAmt
Fundraising$13,291FundraisingAmt

Other Expenses OtherExpensesGrp (4 entries)

DescDescTotalTotalAmtProgram ServicesProgramServicesAmtManagement And GeneralManagementAndGeneralAmtFundraisingFundraisingAmt
CLINICAL STUDIES$330,308$330,308
PRINTING & PUBLICATIONS$215,585$32,377$11,632$171,576
DATA PROCESSING$154,003$40,920$9,553$103,530
POSTAGE, SHIPPING & DEL$119,357$3,891$15,891$99,575

All Other Expenses AllOtherExpensesGrp

FieldValueIRS element (for citing)
Total$165,642TotalAmt
Program Services$63,684ProgramServicesAmt
Management And General$45,320ManagementAndGeneralAmt
Fundraising$56,638FundraisingAmt

Total Functional Expenses TotalFunctionalExpensesGrp

FieldValueIRS element (for citing)
Total$26,772,083TotalAmt
Program Services$21,623,963ProgramServicesAmt
Management And General$2,369,239ManagementAndGeneralAmt
Fundraising$2,778,881FundraisingAmt

Cash Non Interest Bearing CashNonInterestBearingGrp

FieldValueIRS element (for citing)
BOY$3,877,555BOYAmt
EOY$12,383,714EOYAmt

Savings And Temp Cash Invst SavingsAndTempCashInvstGrp

FieldValueIRS element (for citing)
BOY$846,030BOYAmt
EOY$847,554EOYAmt

Pledges And Grants Receivable PledgesAndGrantsReceivableGrp

FieldValueIRS element (for citing)
BOY$15,931,284BOYAmt
EOY$2,944,619EOYAmt

Accounts Receivable AccountsReceivableGrp

FieldValueIRS element (for citing)
BOY$545,275BOYAmt
EOY$332,914EOYAmt

Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp

FieldValueIRS element (for citing)
BOY$193,080BOYAmt
EOY$370,260EOYAmt
FieldValueIRS element (for citing)
Land Bldg Equip Cost Or Other Bss$1,111,481LandBldgEquipCostOrOtherBssAmt
Land Bldg Equip Accum Deprec$835,817LandBldgEquipAccumDeprecAmt

Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp

FieldValueIRS element (for citing)
BOY$390,827BOYAmt
EOY$275,664EOYAmt

Investments Pub Traded Sec InvestmentsPubTradedSecGrp

FieldValueIRS element (for citing)
BOY$80,441,611BOYAmt
EOY$92,239,618EOYAmt

Investments Other Securities InvestmentsOtherSecuritiesGrp

FieldValueIRS element (for citing)
BOY$708,544BOYAmt
EOY$1,025,732EOYAmt

Other Assets Total OtherAssetsTotalGrp

FieldValueIRS element (for citing)
BOY$473,935BOYAmt
EOY$489,871EOYAmt

Total Assets TotalAssetsGrp

FieldValueIRS element (for citing)
BOY$103,408,141BOYAmt
EOY$110,909,946EOYAmt

Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp

FieldValueIRS element (for citing)
BOY$511,502BOYAmt
EOY$763,708EOYAmt

Grants Payable GrantsPayableGrp

FieldValueIRS element (for citing)
BOY$39,843,096BOYAmt
EOY$39,844,509EOYAmt

Deferred Revenue DeferredRevenueGrp

FieldValueIRS element (for citing)
EOY$42,880EOYAmt

Unsecured Notes Loans Payable UnsecuredNotesLoansPayableGrp

FieldValueIRS element (for citing)
BOY$698,800BOYAmt
EOY$0EOYAmt

Other Liabilities OtherLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$797,688BOYAmt
EOY$772,731EOYAmt

Total Liabilities TotalLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$41,851,086BOYAmt
EOY$41,423,828EOYAmt
FieldValueIRS element (for citing)
Organization Follows FASB117Yes (X)OrganizationFollowsFASB117Ind

No Donor Restriction Net Assets NoDonorRestrictionNetAssetsGrp

FieldValueIRS element (for citing)
BOY$45,047,938BOYAmt
EOY$58,936,120EOYAmt

Donor Restriction Net Assets DonorRestrictionNetAssetsGrp

FieldValueIRS element (for citing)
BOY$16,509,117BOYAmt
EOY$10,549,998EOYAmt

Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$61,557,055BOYAmt
EOY$69,486,118EOYAmt

Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$103,408,141BOYAmt
EOY$110,909,946EOYAmt
FieldValueIRS element (for citing)
Info In Schedule O Part XIYes (X)InfoInScheduleOPartXIInd
Reconcilation Revenue Expnss-$2,992,053ReconcilationRevenueExpnssAmt
Net Unrlzd Gains Losses Invst$7,278,535NetUnrlzdGainsLossesInvstAmt
Other Changes In Net Assets$3,642,581OtherChangesInNetAssetsAmt
Method Of Accounting AccrualYes (X)MethodOfAccountingAccrualInd
Accountant Compile Or Review0AccountantCompileOrReviewInd
FS AuditedYes (1)FSAuditedInd

FS Audited Basis FSAuditedBasisGrp

FieldValueIRS element (for citing)
Consolidated Basis Fincl StmtYes (X)ConsolidatedBasisFinclStmtInd
FieldValueIRS element (for citing)
Audit CommitteeYes (1)AuditCommitteeInd
Federal Grant Audit Required0FederalGrantAuditRequiredInd

Schedule A IRS990ScheduleA

FieldValueIRS element (for citing)
Public Organization170Yes (X)PublicOrganization170Ind

Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$23,693,133CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$15,396,535CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$17,673,622CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$41,539,746CurrentTaxYearMinus1YearAmt
Current Tax Year$18,941,837CurrentTaxYearAmt
Total$117,244,873TotalAmt

Total Calendar Year170 TotalCalendarYear170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$23,693,133CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$15,396,535CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$17,673,622CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$41,539,746CurrentTaxYearMinus1YearAmt
Current Tax Year$18,941,837CurrentTaxYearAmt
Total$117,244,873TotalAmt
FieldValueIRS element (for citing)
Substantial Contributors Tot$53,466,414SubstantialContributorsTotAmt
Public Support Total170$63,778,459PublicSupportTotal170Amt

Gross Investment Income170 GrossInvestmentIncome170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$1,314,981CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$1,336,303CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$1,445,946CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$1,614,390CurrentTaxYearMinus1YearAmt
Current Tax Year$2,025,770CurrentTaxYearAmt
Total$7,737,390TotalAmt

Other Income170 OtherIncome170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$204CurrentTaxYearMinus4YearsAmt
Total$204TotalAmt
FieldValueIRS element (for citing)
Total Support$124,982,467TotalSupportAmt
Gross Receipts Rltd Activities$5,143,208GrossReceiptsRltdActivitiesAmt
Public Support CY1700.51030PublicSupportCY170Pct
Public Support PY1700.48800PublicSupportPY170Pct
Thirty Thr Pct Suprt Tests CY170Yes (X)ThirtyThrPctSuprtTestsCY170Ind

Schedule B IRS990ScheduleB

Contributor Information ContributorInformationGrp

FieldValueIRS element (for citing)
ContributorRESTRICTEDContributorNum

Contributor Business Name ContributorBusinessName

FieldValueIRS element (for citing)
Business Name Line1RESTRICTEDBusinessNameLine1

Contributor US Address ContributorUSAddress

FieldValueIRS element (for citing)
Address Line1RESTRICTEDAddressLine1
Address Line2RESTRICTEDAddressLine2
CityRESTRICTEDCity
StateRESTRICTEDState
ZIP CodeRESTRICTEDZIPCode
FieldValueIRS element (for citing)
Total ContributionsRESTRICTEDTotalContributionsAmt

Schedule C IRS990ScheduleC

Total Direct Lobbying TotalDirectLobbyingGrp

FieldValueIRS element (for citing)
Filing Organizations Total$647,293FilingOrganizationsTotalAmt

Total Lobbying Expend TotalLobbyingExpendGrp

FieldValueIRS element (for citing)
Filing Organizations Total$647,293FilingOrganizationsTotalAmt

Other Exempt Purpose Expend OtherExemptPurposeExpendGrp

FieldValueIRS element (for citing)
Filing Organizations Total$26,124,790FilingOrganizationsTotalAmt

Total Exempt Purpose Expend TotalExemptPurposeExpendGrp

FieldValueIRS element (for citing)
Filing Organizations Total$26,772,083FilingOrganizationsTotalAmt

Lobbying Nontaxable Amount LobbyingNontaxableAmountGrp

FieldValueIRS element (for citing)
Filing Organizations Total$1,000,000FilingOrganizationsTotalAmt

Grassroots Nontaxable GrassrootsNontaxableGrp

FieldValueIRS element (for citing)
Filing Organizations Total$250,000FilingOrganizationsTotalAmt

Tot Lbbyng Grassroot Mns Non Tx TotLbbyngGrassrootMnsNonTxGrp

FieldValueIRS element (for citing)
Filing Organizations Total$0FilingOrganizationsTotalAmt

Tot Lbby Expend Mns Lbbyng Non Tx TotLbbyExpendMnsLbbyngNonTxGrp

FieldValueIRS element (for citing)
Filing Organizations Total$0FilingOrganizationsTotalAmt

Avg Lobbying Nontaxable Amount AvgLobbyingNontaxableAmountGrp

FieldValueIRS element (for citing)
Current Year Minus3$1,000,000CurrentYearMinus3Amt
Current Year Minus2$1,000,000CurrentYearMinus2Amt
Current Year Minus1$1,000,000CurrentYearMinus1Amt
Current Year$1,000,000CurrentYearAmt
Total$4,000,000TotalAmt
FieldValueIRS element (for citing)
Lobbying Ceiling$6,000,000LobbyingCeilingAmt

Avg Total Lobbying Expend AvgTotalLobbyingExpendGrp

FieldValueIRS element (for citing)
Current Year Minus3$788,377CurrentYearMinus3Amt
Current Year Minus2$846,235CurrentYearMinus2Amt
Current Year Minus1$743,966CurrentYearMinus1Amt
Current Year$647,293CurrentYearAmt
Total$3,025,871TotalAmt

Avg Grassroots Nontaxable AvgGrassrootsNontaxableGrp

FieldValueIRS element (for citing)
Current Year Minus3$250,000CurrentYearMinus3Amt
Current Year Minus2$250,000CurrentYearMinus2Amt
Current Year Minus1$250,000CurrentYearMinus1Amt
Current Year$250,000CurrentYearAmt
Total$1,000,000TotalAmt
FieldValueIRS element (for citing)
Grassroots Ceiling$1,500,000GrassrootsCeilingAmt

Schedule D IRS990ScheduleD

CY Endwmt Fund CYEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$56,586,437BeginningYearBalanceAmt
Investment Earnings Or Losses$7,839,333InvestmentEarningsOrLossesAmt
Other Expenditures$3,111,233OtherExpendituresAmt
End Year Balance$61,314,537EndYearBalanceAmt

CY Minus1 Yr Endwmt Fund CYMinus1YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$51,813,456BeginningYearBalanceAmt
Investment Earnings Or Losses$6,226,708InvestmentEarningsOrLossesAmt
Other Expenditures$1,453,727OtherExpendituresAmt
End Year Balance$56,586,437EndYearBalanceAmt

CY Minus2 Yr Endwmt Fund CYMinus2YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$46,122,925BeginningYearBalanceAmt
Investment Earnings Or Losses$8,404,231InvestmentEarningsOrLossesAmt
Other Expenditures$2,713,456OtherExpendituresAmt
End Year Balance$51,813,456EndYearBalanceAmt

CY Minus3 Yr Endwmt Fund CYMinus3YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$51,742,397BeginningYearBalanceAmt
Investment Earnings Or Losses-$2,936,193InvestmentEarningsOrLossesAmt
Other Expenditures$2,683,279OtherExpendituresAmt
End Year Balance$46,122,925EndYearBalanceAmt

CY Minus4 Yr Endwmt Fund CYMinus4YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$45,863,827BeginningYearBalanceAmt
Investment Earnings Or Losses$8,478,913InvestmentEarningsOrLossesAmt
Other Expenditures$2,600,343OtherExpendituresAmt
End Year Balance$51,742,397EndYearBalanceAmt
FieldValueIRS element (for citing)
Board Designated Balance EOY1.00000BoardDesignatedBalanceEOYPct
Endowments Held Unrelated Org0EndowmentsHeldUnrelatedOrgInd
Endowments Held Related Org0EndowmentsHeldRelatedOrgInd

Leasehold Improvements LeaseholdImprovementsGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$424,912OtherCostOrOtherBasisAmt
Depreciation$229,038DepreciationAmt
Book Value$195,874BookValueAmt

Equipment EquipmentGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$686,569OtherCostOrOtherBasisAmt
Depreciation$606,779DepreciationAmt
Book Value$79,790BookValueAmt
FieldValueIRS element (for citing)
Total Book Value Land Buildings$275,664TotalBookValueLandBuildingsAmt

Other Liabilities Org OtherLiabilitiesOrgGrp

FieldValueIRS element (for citing)
DescDEFERRED RENTDesc
Amt$772,731Amt
FieldValueIRS element (for citing)
Total Liability$772,731TotalLiabilityAmt
Total Rev Etc Audited Fincl Stmt$34,477,283TotalRevEtcAuditedFinclStmtAmt
Net Unrealized Gains Invst$7,278,535NetUnrealizedGainsInvstAmt
Recoveries Prior Year Grants$3,613,650RecoveriesPriorYearGrantsAmt
Revenue Not Reported$10,892,185RevenueNotReportedAmt
Revenue Subtotal$23,585,098RevenueSubtotalAmt
Investment Expenses Not Incld$194,932InvestmentExpensesNotIncldAmt
Revenue Not Reported Fincl Stmt$194,932RevenueNotReportedFinclStmtAmt
Total Revenue Per Form990$23,780,030TotalRevenuePerForm990Amt
Tot Expns Etc Audited Fincl Stmt$26,548,220TotExpnsEtcAuditedFinclStmtAmt
Expenses Not Reported$0ExpensesNotReportedAmt
Expenses Subtotal$26,548,220ExpensesSubtotalAmt
Investment Expenses Not Incld2$194,932InvestmentExpensesNotIncld2Amt
Other Expenses Not Included$28,931OtherExpensesNotIncludedAmt
Expenses Not Rpt Fincl Stmt$223,863ExpensesNotRptFinclStmtAmt
Total Expenses Per Form990$26,772,083TotalExpensesPerForm990Amt

Supplemental Information Detail SupplementalInformationDetail (3 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
PART V, LINE 4:BOARD DESIGNATED (QUASI) ENDOWMENT FUND INCOME TO BE USED FOR RESEARCH PROGRAM GRANTS. PRINCIPAL TO REMAIN INTACT UNLESS HIGH PRIORITY LUPUS RESEARCH PROJECTS NEED TO BE FUNDED THAT COULD NOT BE FUNDED OTHERWISE.
PART XII, LINE 4B - OTHER ADJUSTMENTS:RETURN OF GRANTS & ADJUSTMENTS 28,931.
PART PART XII, LINE 4BUNUSED PORTIONS OF GRANTS RETURNED TO LRA THAT WERE PAID IN PREVIOUS YEARS IN THE AMOUNT OF $28,931. THESE AMOUNTS ARE RECONCILING ITEMS BETWEEN THE REVENUE AND EXPENSES FROM THE AUDITED FINANCIAL STATEMENTS AND THOSE REPORTED ON FORM 990.

Schedule F IRS990ScheduleF

FieldValueIRS element (for citing)
Grant Records MaintainedYes (1)GrantRecordsMaintainedInd

Account Activities Outside US AccountActivitiesOutsideUSGrp (3 entries)

RegionRegionTxtOfficesOfficesCntEmployeeEmployeeCntType Of Activities ConductedTypeOfActivitiesConductedTxtRegion Total ExpendituresRegionTotalExpendituresAmt
NORTH AMERICA - CANADA AND MEXICO, BUT NOT THE UNITED STATES00GRANTS TO RECIPIENTS$634,745
EAST ASIA AND THE PACIFIC00GRANTS TO RECIPIENTS$596,917
EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM00GRANTS TO RECIPIENTS$443,349
FieldValueIRS element (for citing)
Subtotal Offices0SubtotalOfficesCnt
Subtotal Employees0SubtotalEmployeesCnt
Continuation Total Office0ContinuationTotalOfficeCnt
Continuation Total Employee0ContinuationTotalEmployeeCnt
Total Office0TotalOfficeCnt
Total Employee0TotalEmployeeCnt
Subtotal Spent$1,675,011SubtotalSpentAmt
Continuation Spent$0ContinuationSpentAmt
Total Spent$1,675,011TotalSpentAmt

Grants To Org Outside US GrantsToOrgOutsideUSGrp (16 entries)

RegionRegionTxtPurpose Of GrantPurposeOfGrantTxtCash GrantCashGrantAmtManner Of Cash DisbursementMannerOfCashDisbursementTxtNon Cash AssistanceNonCashAssistanceAmt
NORTH AMERICALUPUS RESEARCH$80,000ACH$0
NORTH AMERICALUPUS RESEARCH$80,000ACH$0
NORTH AMERICALUPUS RESEARCH$80,000ACH$0
NORTH AMERICALUPUS RESEARCH$90,000ACH$0
NORTH AMERICALUPUS RESEARCH$80,000ACH$0
NORTH AMERICALUPUS RESEARCH$80,000ACH$0
NORTH AMERICALUPUS RESEARCH$80,000ACH$0
NORTH AMERICALUPUS RESEARCH$34,745ACH$0
NORTH AMERICALUPUS RESEARCH$30,000ACH$0
EAST ASIA AND THE PACIFICLUPUS RESEARCH$301,389ACH$0
EAST ASIA AND THE PACIFICLUPUS RESEARCH$291,389WIRE$0
EUROPE (INCLUDING ICELAND AND GREENLAND)LUPUS RESEARCH$120,000WIRE$0
EUROPE (INCLUDING ICELAND AND GREENLAND)LUPUS RESEARCH$10,000WIRE$0
EUROPE (INCLUDING ICELAND AND GREENLAND)LUPUS RESEARCH$14,821WIRE$0
EUROPE (INCLUDING ICELAND AND GREENLAND)LUPUS RESEARCH$291,389WIRE$0
EUROPE (INCLUDING ICELAND AND GREENLAND)LUPUS RESEARCH$7,139WIRE$0
FieldValueIRS element (for citing)
Total501c3 Org7Total501c3OrgCnt
Total Other Org9TotalOtherOrgCnt
Transfer To Foreign Corp0TransferToForeignCorpInd
Interest In Foreign Trust0InterestInForeignTrustInd
Foreign Corp Ownership0ForeignCorpOwnershipInd
Passive Foreign Investmest Co0PassiveForeignInvestmestCoInd
Foreign Partnership0ForeignPartnershipInd
Boycott Countries0BoycottCountriesInd

Supplemental Information Detail SupplementalInformationDetail (2 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
PART I, LINE 2:PRE AWARD AND APPLICATION PHASE: BEFORE A GRANT IS AWARDED, THE SPONSORING INSTITUTION (SI) MUST AGREE TO THE TERMS AND CONDITIONS OUTLINED IN THE LUPUS RESEARCH ALLIANCE (LRA)'S POLICY STATEMENT FOR RESEARCH GRANTS THAT INCLUDE: CONFIRMATION BY THE PRINCIPAL INVESTIGATOR (PI) AND THE SI THAT FUNDS WILL ONLY BE USED AS DESCRIBED IN THE APPLICATION SUBMITTED AND APPROVED FOR FUNDING. AGREE THAT PI AND SI ARE BOTH RESPONSIBLE FOR INSURING THAT ALL RESEARCH ACTIVITIES ARE CONDUCTED IN A SAFE, RESPONSIBLE AND ETHICAL MANNER. THEY MUST KEEP UPDATED APPROVAL FROM THE SI'S INSTITUTIONAL REVIEW BOARD AND ANIMAL CARE AND USE COMMITTEE THROUGHOUT THE PROJECT PERIOD. AGREE TO GET APPROVAL FROM THE LRA IF THERE NEEDS TO BE A SIGNIFICANT CHANGE TO THE BUDGET AS SUBMITTED. AGREE TO GET APPROVAL FROM THE LRA IF ADDITIONAL TIME IS NEEDED TO COMPLETE THE PROJECT WORK. AGREE TO SUBMIT ALL DELIVERABLES AND REPORTS AS SCHEDULED: (A) ANNUAL PROGRESS REPORTS AND (B) ANNUAL FINANCIAL REPORTS ARE REQUIRED. TRAVEL FUNDS PROVIDED AS PART OF THE PROJECT ARE EXPECTED TO BE USED TO ATTEND THE LRA'S ANNUAL MEETING FORUM FOR DISCOVERY. CONFIRMATION THAT THERE IS NO OTHER ACTIVE OF PENDING SUPPORT FOR THE SPECIFIC PROJECT THAT IS THE SUBJECT OF THE GRANT. POST AWARD: THE PI AND A REPRESENTATIVE FROM THE SI MUST SUBMIT: A SIGNED LETTER OF ACCEPTANCE CONFIRMING THE FOLLOWING: A. PI'S WILLINGNESS TO ADHERE TO THE TERMS OF THE BUDGET AS OUTLINED IN THE FUNDING LETTER. B. PI'S WILLINGNESS TO COMPLY WITH ALL OF THE CONDITIONS OUTLINED IN THE POLICY STATEMENT FOR RESEARCH GRANTS AND PATENT AND INTELLECTUAL PROPERTY POLICY. C. THERE IS NO OVERLAPPING SOURCE OF SUPPORT FOR THE SPECIFIC PROJECT THAT IS THE SUBJECT OF THIS GRANT. OTHER FUNDING THAT MIGHT BE CONSTRUED AS OVERLAPPING, MUST BE EXPLAINED IN DETAIL. D. THE FOLLOWING STATEMENT SHOULD APPEAR AT THE CONCLUSION OF THE LETTER OF ACCEPTANCE, "I AGREE TO ACCEPT RESPONSIBILITY FOR THE SCIENTIFIC AND TECHNICAL CONDUCT OF THE RESEARCH PROJECT AND FOR THE PROVISION OF ALL PROGRESS REPORTS REQUIRED FROM INVESTIGATORS FUNDED BY A GRANT FROM THE LUPUS RESEARCH ALLIANCE." IF AN EXTENSION IS AWARDED ADDITIONAL INTERIM PROGRESS REPORTS AND BUDGET RECONCILIATIONS ARE REQUIRED TO BE SUBMITTED. AT THE END OF THE GRANT A FINAL PROGRESS REPORT AND BUDGET RECONCILIATION IS REQUIRED TO BE SUBMITTED, UNSPENT AMOUNTS ARE TO BE RETURNED TO THE LRA. ALL SIS RECEIVE A PAYMENT AND DELIVERABLE SCHEDULE AND THE PROJECT IS MONITORED BY: O PERIODIC PROGRESS REPORTS O PERIODIC BUDGET RECONCILIATIONS ALL PUBLICATIONS RELATED TO THE GRANT ARE TO BE SUBMITTED TO THE LRA THE LRA MUST BE LISTED AS A FUNDER IN ANY PUBLISHED PAPERS AND VERBAL OR POSTER PRESENTATIONS THE SI MUST SUBMIT A COPY OF THE IRS OR OTHER TAX GOVERNING INSTITUTION CONFIRMING THE TAX STATUS OF THE SI
PART III ACCOUNTING METHOD:

Schedule G IRS990ScheduleG

FieldValueIRS element (for citing)
Mail SolicitationsYes (X)MailSolicitationsInd
Email SolicitationsYes (X)EmailSolicitationsInd
In Person SolicitationsYes (X)InPersonSolicitationsInd
Solicitation Of Non Govt GrantsYes (X)SolicitationOfNonGovtGrantsInd
Special Fundraising EventsYes (X)SpecialFundraisingEventsInd
Agrmt Prof Fundraising ActyYes (1)AgrmtProfFundraisingActyInd

Fundraiser Activity Info FundraiserActivityInfoGrp

Organization Business Name OrganizationBusinessName

FieldValueIRS element (for citing)
Business Name Line1DS CONSULTING GROUPBusinessNameLine1Txt

US Address USAddress

FieldValueIRS element (for citing)
Address Line1845 THIRD AVENUE 6TH FLOORAddressLine1Txt
CityNEW YORKCityNm
State AbbreviationNYStateAbbreviationCd
ZIP10022ZIPCd
FieldValueIRS element (for citing)
ActivitySPECIAL EVENT CONSULTANT NY GALAActivityTxt
Fundraiser Control Of FundsYes (1)FundraiserControlOfFundsInd
Gross Receipts$7,292,511GrossReceiptsAmt
Retained By Contractor$65,000RetainedByContractorAmt
Net To Organization$7,292,511NetToOrganizationAmt
FieldValueIRS element (for citing)
Total Gross Receipts$7,292,511TotalGrossReceiptsAmt
Total Retained By Contractors$65,000TotalRetainedByContractorsAmt
Total Net To Organization$7,292,511TotalNetToOrganizationAmt
Licensed StatesALLicensedStatesCd
Licensed StatesAKLicensedStatesCd
Licensed StatesAZLicensedStatesCd
Licensed StatesARLicensedStatesCd
Licensed StatesCALicensedStatesCd
Licensed StatesCOLicensedStatesCd
Licensed StatesCTLicensedStatesCd
Licensed StatesDELicensedStatesCd
Licensed StatesFLLicensedStatesCd
Licensed StatesGALicensedStatesCd
Licensed StatesHILicensedStatesCd
Licensed StatesIDLicensedStatesCd
Licensed StatesILLicensedStatesCd
Licensed StatesINLicensedStatesCd
Licensed StatesIALicensedStatesCd
Licensed StatesKSLicensedStatesCd
Licensed StatesKYLicensedStatesCd
Licensed StatesLALicensedStatesCd
Licensed StatesMELicensedStatesCd
Licensed StatesMDLicensedStatesCd
Licensed StatesMALicensedStatesCd
Licensed StatesMILicensedStatesCd
Licensed StatesMNLicensedStatesCd
Licensed StatesMSLicensedStatesCd
Licensed StatesMOLicensedStatesCd
Licensed StatesMTLicensedStatesCd
Licensed StatesNELicensedStatesCd
Licensed StatesNVLicensedStatesCd
Licensed StatesNHLicensedStatesCd
Licensed StatesNJLicensedStatesCd
Licensed StatesNMLicensedStatesCd
Licensed StatesNYLicensedStatesCd
Licensed StatesNCLicensedStatesCd
Licensed StatesNDLicensedStatesCd
Licensed StatesOHLicensedStatesCd
Licensed StatesOKLicensedStatesCd
Licensed StatesORLicensedStatesCd
Licensed StatesPALicensedStatesCd
Licensed StatesRILicensedStatesCd
Licensed StatesSCLicensedStatesCd
Licensed StatesSDLicensedStatesCd
Licensed StatesTNLicensedStatesCd
Licensed StatesTXLicensedStatesCd
Licensed StatesVTLicensedStatesCd
Licensed StatesVALicensedStatesCd
Licensed StatesWALicensedStatesCd
Licensed StatesWVLicensedStatesCd
Licensed StatesWILicensedStatesCd
Licensed StatesWYLicensedStatesCd

Fundraising Event Information FundraisingEventInformationGrp

FieldValueIRS element (for citing)
Event1GALA CELEBRATIONEvent1Nm
Gross Receipts Event1$7,323,415GrossReceiptsEvent1Amt
Charitable Contri Event1$6,863,745CharitableContriEvent1Amt
Gross Revenue Event1$459,670GrossRevenueEvent1Amt
Food And Beverage Event1$313,972FoodAndBeverageEvent1Amt
Other Direct Expenses Event1$145,698OtherDirectExpensesEvent1Amt
Event2WALK-A-THONSEvent2Nm
Gross Receipts Event2$1,076,982GrossReceiptsEvent2Amt
Charitable Contri Event2$944,764CharitableContriEvent2Amt
Gross Revenue Event2$132,218GrossRevenueEvent2Amt
Other Direct Expenses Event2$132,218OtherDirectExpensesEvent2Amt
Gross Receipts Total$8,400,397GrossReceiptsTotalAmt
Charitable Contributions Tot$7,808,509CharitableContributionsTotAmt
Gross Revenue Total Events$591,888GrossRevenueTotalEventsAmt
Food And Beverage Total Events$313,972FoodAndBeverageTotalEventsAmt
Oth Direct Expnss Total Events$277,916OthDirectExpnssTotalEventsAmt
Direct Expense Summary Events$591,888DirectExpenseSummaryEventsAmt
Net Income Summary$0NetIncomeSummaryAmt

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferenceSCHEDULE G, PART I, LINE 2B, COLUMN (V)FormAndLineReferenceDesc
ExplanationDS CONSULTING PLANNED AND MANAGED ALR'S GALA EVENT. CONTRACT AMOUNT FOR THE PERIOD COVERING 1/1/21 - 12/31/21 WAS $65,000 PLUS REIMBURSABLE EXPENSES.ExplanationTxt

Schedule I IRS990ScheduleI

FieldValueIRS element (for citing)
Grant Records MaintainedYes (1)GrantRecordsMaintainedInd

Recipient Table RecipientTable (55 entries)

Address Line1USAddress/AddressLine1TxtCityUSAddress/CityNmState AbbreviationUSAddress/StateAbbreviationCdZIPUSAddress/ZIPCdRecipient EINRecipientEINIRC SectionIRCSectionDescCash GrantCashGrantAmtNon Cash AssistanceNonCashAssistanceAmtValuation Method UsedValuationMethodUsedDescPurpose Of GrantPurposeOfGrantTxtAddress Line2USAddress/AddressLine2Txt
ALBERT EINSTEIN COLLEGE OF MEDICINE
1300 MORRIS PARK AVEBRONXNY10461472209056501(C)(3)$80,000$0BOOKLUPUS RESEARCH
BENAROYA RESEARCH INSTITUTE AT VIRGINIA MASON
1201 NINTH AVESEATTLEWA98101910653422501(C)(3)$10,813$0BOOKLUPUS RESEARCH
BETH ISRAEL DEACONESS MEDICAL CENTER
330 BROOKLINE AVENUEBOSTONMA02215042103881501(C)(3)$80,000$0BOOKLUPUS RESEARCH
BOSTON CHILDREN'S HOSPTIAL
300 LONGWOOD AVENUEBOSTONMA02115042774441501(C)(3)$291,389$0BOOKLUPUS RESEARCH
BRIGHAM AND WOMEN'S HOSPITAL
77 AVENUE LOUIS PASTEURBOSTONMA02115042312909501(C)(3)$96,528$0BOOKLUPUS RESEARCH
BROAD INSTITUTE INC
SEVEN CAMBRIDGE CENTERCAMBRIDGEMA02142263428781501(C)(3)$469,092$0BOOKLUPUS RESEARCH
CHILDREN'S HOSPTIAL OF PHILADELPHIA
3401 CIVIC CENTER BOULEVARDPHIALDELPHIAPA19104231352166501(C)(3)$8,611$0BOOKLUPUS RESEARCH
COLUMBIA UNIVERSITY MEDICAL CENTER
154 HAVEN AVE 2ND FLNEW YORKNY10032133598093501(C)(3)$80,000$0BOOKLUPUS RESEARCH
EMORY UNIVERSITY
1762 CLIFTON RD NEATLANTAGA30322580566256501(C)(3)$3,117,140$0BOOKLUPUS RESEARCH
FOUNDATION FOR THE NATIONAL INSTITUTES OF HEALTH INC
9650 ROCKVILLE PIKEBETHESDAMD20814521986675501(C)(3)$100,000$0BOOKLUPUS RESEARCH
HOSPITAL FOR SPECIAL SURGERY
535 E 70TH STREETNEW YORKNY10021131624135501(C)(3)$145,872$0BOOKLUPUS RESEARCH
MASSACHUSETTS GENERAL HOSPITAL
55 FRUIT STREETBOSTONMA02114042697983501(C)(3)$87,176$0BOOKLUPUS RESEARCH
MAYO CLINIC
200 FIRST STREET SWROCHESTERMN55905416011702501(C)(3)$88,611$0BOOKLUPUS RESEARCH
MEDICAL UNIVERSITY OF SOUTH CAROLINA
179 ASHLEY AVENUECHARLESTONSC29425576028985SECTION 115 - SC STA$662,779$0BOOKLUPUS RESEARCH
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
550 FIRST AVENUENEW YORKNY10016135562308501(C)(3)$90,872$0BOOKLUPUS RESEARCH
NORTHWELL HEALTH - DIVISION OF RHEUMATOLOGY
972 BRUSH HOLLOW RD 5TH FLWESTBURYNY11590112673595501(C)(3)$80,000$0BOOKLUPUS RESEARCH
NORTHWESTERN UNIVERSITY
633 CLARK STREETEVANSTONIL60208362167818501(C)(3)$80,000$0BOOKLUPUS RESEARCH
OKLAHOMA MEDICAL RESEARCH FOUNDATION
825 NE 13TH STREETOKLAHOMA CITYOK73104730580274501(C)(3)$105,818$0BOOKLUPUS RESEARCH
PENNSYLVANIA STATE UNIVERSITY
ONE OLD MAINUNIVERSITY PARKPA16802246000376501(C)(3)$80,000$0BOOKLUPUS RESEARCH
REGENTS OF THE UNIVERSITY OF CALIFORNIA AT BERKELEY
2200 UNIVERSITY AVEBERKELEYCA94720946002123501(C)(3)$291,389$0BOOKLUPUS RESEARCH
REGENTS OF THE UNIVERSITY OF CALIFORNIA IRVINE
5171 CALIFORNIA AVENUE STE 150IRVINECA92697952226406501(C)(3)$80,000$0BOOKLUPUS RESEARCH
RUSH UNIVERSITY MEDICAL CENTER
1653 WEST CONGRESS PARKWAYCHICAGOIL60612362174823501(C)(3)$80,000$0BOOKLUPUS RESEARCH
ST JUDE CHILDREN'S HOSPITAL
262 DANNY THOMAS PLMEMPHISTN381053678620646012501(C)(3)$16,528$0BOOKLUPUS RESEARCH
STANFORD UNIVERSITY
3145 PORTER DRIVEPALO ALTOCA94304941156365501(C)(3)$94,352$0BOOKLUPUS RESEARCH
STATE UNIVERSITY OF NY AT STONY BROOK
ONE LINCOLN CENTERSYRACUSENY13202141368361501(C)(3)$291,386$0BOOKLUPUS RESEARCH
TEMPLE UNIVERSITY
1801 N BROAD STREETPHILADELPHIAPA19122231365971501(C)(3)$80,000$0BOOKLUPUS RESEARCH
TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER
3601 4TH STREETLUBBOCKTX79430752668014TX STATE GOVERNMENT$25,459$0BOOKLUPUS RESEARCH
THE FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH
350 COMMUNITYMANHASSETNY11030112673595501(C)(3)$134,413$0BOOKLUPUS RESEARCH
THE METROHEALTH SYSTEM
2500 METROHEALTH DRIVECLEVELANDOH44109346004382SECTION 115 - OH STA$80,000$0BOOKLUPUS RESEARCH
THE OHIO STATE UNIVERSITY
1960 KENNY ROADCOLUMBUSOH43210311702164SECTION 115 - OH STA$80,000$0BOOKLUPUS RESEARCH
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA LOS ANGELES
10920 WILSHIRE BLVD STE 620LOS ANGELESCA90024956006143501(C)(3)$80,000$0BOOKLUPUS RESEARCH
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA SAN DIEGO
9500 GILMAN DRIVE MC0934LA JOLLACA92093956006144501(C)(3)$579,275$0BOOKLUPUS RESEARCH
THE RESEARCH FOUNDATION OF SUNY
35 STATE STREETALBANYNY12201141368361501(C)(3)$80,000$0BOOKLUPUS RESEARCH
THE UNIVERSITY OF CHICAGO
5801 SOUTH ELLIS AVENUE STE 501CHICAGOIL60637362177139501(C)(3)$90,586$0BOOKLUPUS RESEARCH
THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL
6000 FELDWOOD ROADCOLLEGE PARKGA30349566001393501(C)(3)$148,317$0BOOKLUPUS RESEARCH
TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
3451 WALNUT STREETPHILADELPHIAPA19104231352685501(C)(3)$119,508$0BOOKLUPUS RESEARCH
UNIVERSITY OF ALABAMA AT BIRMINGHAM
1530 3RD AVE SBIRMINGHAMAL35294636005396501(C)(3)$96,446$0BOOKLUPUS RESEARCH
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
2200 UNIVERSITY HALLBERKELEYCA94720946036493501(C)(3)$439,013$0BOOKLUPUS RESEARCH
UNIVERSITY OF COLORADO ANSCHUTZ MEDICAL CAMPUS
3100 MARINE ST 6TH FLBOULDERCO80309846000555501(C)(3)$118,611$0BOOKLUPUS RESEARCH
UNIVERSITY OF FLORIDA
207 TIGERT HALLGAINSEVILLEFL32611596002052FL STATE GOVERNMENT$80,000$0BOOKLUPUS RESEARCH
UNIVERSITY OF HOUSTON
4800 CALHOUN ROADHOUSTONTX77004746001399501(C)(3)$8,611$0BOOKLUPUS RESEARCH
UNIVERSITY OF MARYLAND BALTIMORE
620 W LEXINGON STREET 4TH FLBALTIMOREMD21201521830242SECTION 115 - MD STA$80,000$0BOOKLUPUS RESEARCH
UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL
55 LAKE AVENUEWORCESTERMA01655043167325MA STATE GOVERNMENT$385,737$0BOOKLUPUS RESEARCH
UNIVERSITY OF MIAMI
1320 S DIXIE HIGHWAY GABLES ONECORAL GABLESFL33146590624458501(C)(3)$80,000$0BOOKLUPUS RESEARCHTOWER 650
UNIVERSITY OF MICHIGAN
503 THOMPSON STREETANN ARBORMI48109386006309501(C)(3)$105,139$0BOOKLUPUS RESEARCH
UNIVERSITY OF PITTSBURGH
123 UNIVERSITY PLACEPITTSBURGHPA15213250965591501(C)(3)$80,000$0BOOKLUPUS RESEARCH
UNIVERSITY OF ROCHESTER
518 HYLAN BUILDINGROCHESTERNY14627160743209501(C)(3)$80,000$0BOOKLUPUS RESEARCH
UNIVERSITY OF TEXAS AT SAN ANTONIO
7703 FLOYD CURL DRIVESAN ANTONIOTX782293900746000203TX STATE GOVERNMENT$16,528$0BOOKLUPUS RESEARCH
UNIVERSITY OF WASHINGTON
3917 UNIVERSITY WAY NESEATTLEWA98195916001537SECTION 115 - WA STA$88,429$0BOOKLUPUS RESEARCH
UT SOUTHWESTERN MEDICAL CENTER
5323 HARRY HINES BLVDDALLASTX75390746000203TX STATE GOVERNMENT$80,000$0BOOKLUPUS RESEARCH
VANDERBILT UNIVERSITY MEDICAL CENTER
1211 MEDICAL CENTER DRIVENASHVILLETN37232352528741501(C)(3)$92,750$0BOOKLUPUS RESEARCH
WAKE FOREST UNIVERSITY HEALTH SCIENCES
MEDICAL CENTER BLVDWINSTONSALEMNC27157223849199501(C)(3)$80,000$0BOOKLUPUS RESEARCH
WALLACE RHEUMATIC STUDIES CENTER LLC
8737 BENVERLY BLVD STE 301W HOLLYWOODCA90048455434561501(C)(3)$80,000$0BOOKLUPUS RESEARCH
WEILL MEDICAL COLLEGE OF CORNELL UNIVERSITY
1300 YORK AVENUENEW YORKNY10065131623978501(C)(3)$3,154,756$0BOOKLUPUS RESEARCH
YALE UNIVERSITY
BOX 208239NEW HAVENCT06520060646973501(C)(3)$88,611$0BOOKLUPUS RESEARCH
FieldValueIRS element (for citing)
Total501c3 Org46Total501c3OrgCnt
Total Other Org10TotalOtherOrgCnt

Grants Other Asst To Indiv In US GrantsOtherAsstToIndivInUSGrp

FieldValueIRS element (for citing)
Grant TypeLUPUS EMERGENCY GRANT - $500 MAX PER PERSONGrantTypeTxt
Recipient28RecipientCnt
Cash Grant$11,736CashGrantAmt
Valuation Method UsedBILLSValuationMethodUsedDesc
Non Cash AssistanceLUPUS EMERGENCY GRANT - $500 MAX PER PERSONNonCashAssistanceDesc

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferencePART I, LINE 2:FormAndLineReferenceDesc
ExplanationPRE AWARD AND APPLICATION PHASE: BEFORE A GRANT IS AWARDED, THE SPONSORING INSTITUTION (SI) MUST AGREE TO THE TERMS AND CONDITIONS OUTLINED IN THE LUPUS RESEARCH ALLIANCE (LRA)'S POLICY STATEMENT FOR RESEARCH GRANTS THAT INCLUDE: CONFIRMATION BY THE PRINCIPAL INVESTIGATOR (PI) AND THE SI THAT FUNDS WILL ONLY BE USED AS DESCRIBED IN THE APPLICATION SUBMITTED AND APPROVED FOR FUNDING. AGREE THAT PI AND SI ARE BOTH RESPONSIBLE FOR INSURING THAT ALL RESEARCH ACTIVITIES ARE CONDUCTED IN A SAFE, RESPONSIBLE AND ETHICAL MANNER. THEY MUST KEEP UPDATED APPROVAL FROM THE SI'S INSTITUTIONAL REVIEW BOARD AND ANIMAL CARE AND USE COMMITTEE THROUGHOUT THE PROJECT PERIOD. AGREE TO GET APPROVAL FROM THE LRA IF THERE NEEDS TO BE A SIGNIFICANT CHANGE TO THE BUDGET AS SUBMITTED. AGREE TO GET APPROVAL FROM THE LRA IF ADDITIONAL TIME IS NEEDED TO COMPLETE THE PROJECT WORK. AGREE TO SUBMIT ALL DELIVERABLES AND REPORTS AS SCHEDULED: (A) ANNUAL PROGRESS REPORTS AND (B) ANNUAL FINANCIAL REPORTS ARE REQUIRED. TRAVEL FUNDS PROVIDED AS PART OF THE PROJECT ARE EXPECTED TO BE USED TO ATTEND THE LRA'S ANNUAL MEETING FORUM FOR DISCOVERY. CONFIRMATION THAT THERE IS NO OTHER ACTIVE OF PENDING SUPPORT FOR THE SPECIFIC PROJECT THAT IS THE SUBJECT OF THE GRANT. POST AWARD: THE PI AND A REPRESENTATIVE FROM THE SI MUST SUBMIT: A SIGNED LETTER OF ACCEPTANCE CONFIRMING THE FOLLOWING: A. PI'S WILLINGNESS TO ADHERE TO THE TERMS OF THE BUDGET AS OUTLINED IN THE FUNDING LETTER. B. PI'S WILLINGNESS TO COMPLY WITH ALL OF THE CONDITIONS OUTLINED IN THE POLICY STATEMENT FOR RESEARCH GRANTS AND PATENT AND INTELLECTUAL PROPERTY POLICY. C. THERE IS NO OVERLAPPING SOURCE OF SUPPORT FOR THE SPECIFIC PROJECT THAT IS THE SUBJECT OF THIS GRANT. OTHER FUNDING THAT MIGHT BE CONSTRUED AS OVERLAPPING, MUST BE EXPLAINED IN DETAIL. D. THE FOLLOWING STATEMENT SHOULD APPEAR AT THE CONCLUSION OF THE LETTER OF ACCEPTANCE, "I AGREE TO ACCEPT RESPONSIBILITY FOR THE SCIENTIFIC AND TECHNICAL CONDUCT OF THE RESEARCH PROJECT AND FOR THE PROVISION OF ALL PROGRESS REPORTS REQUIRED FROM INVESTIGATORS FUNDED BY A GRANT FROM THE LUPUS RESEARCH ALLIANCE." IF AN EXTENSION IS AWARDED ADDITIONAL INTERIM PROGRESS REPORTS AND BUDGET RECONCILIATIONS ARE REQUIRED TO BE SUBMITTED. AT THE END OF THE GRANT A FINAL PROGRESS REPORT AND BUDGET RECONCILIATION IS REQUIRED TO BE SUBMITTED, UNSPENT AMOUNTS ARE TO BE RETURNED TO THE LRA. ALL SIS RECEIVE A PAYMENT AND DELIVERABLE SCHEDULE AND THE PROJECT IS MONITORED BY: O PERIODIC PROGRESS REPORTS O PERIODIC BUDGET RECONCILIATIONS ALL PUBLICATIONS RELATED TO THE GRANT ARE TO BE SUBMITTED TO THE LRA THE LRA MUST BE LISTED AS A FUNDER IN ANY PUBLISHED PAPERS AND VERBAL OR POSTER PRESENTATIONS THE SI MUST SUBMIT A COPY OF THE IRS OR OTHER TAX GOVERNING INSTITUTION CONFIRMING THE TAX STATUS OF THE SIExplanationTxt

Schedule J IRS990ScheduleJ

FieldValueIRS element (for citing)
Compensation CommitteeYes (X)CompensationCommitteeInd
Form990 Of Other OrganizationsYes (X)Form990OfOtherOrganizationsInd
Written Employment ContractYes (X)WrittenEmploymentContractInd
Compensation SurveyYes (X)CompensationSurveyInd
Board Or Committee ApprovalYes (X)BoardOrCommitteeApprovalInd
Severance Payment0SeverancePaymentInd
Supplemental Nonqual Rtr Plan0SupplementalNonqualRtrPlanInd
Equity Based Comp Arrngm0EquityBasedCompArrngmInd
Comp Based On Revenue Of Flng Org0CompBasedOnRevenueOfFlngOrgInd
Comp Bsd On Rev Related Orgs0CompBsdOnRevRelatedOrgsInd
Comp Bsd Net Earns Flng Org0CompBsdNetEarnsFlngOrgInd
Comp Bsd Net Earns Rltd Orgs0CompBsdNetEarnsRltdOrgsInd
Any Non Fixed Payments0AnyNonFixedPaymentsInd
Initial Contract Exception0InitialContractExceptionInd

Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (10 entries)

TitleTitleTxtBase Compensation Filing OrgBaseCompensationFilingOrgAmtCompensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmtBonus Filing OrganizationBonusFilingOrganizationAmountBonus Related OrganizationsBonusRelatedOrganizationsAmtOther Compensation Filing OrgOtherCompensationFilingOrgAmtOther Compensation Rltd OrgsOtherCompensationRltdOrgsAmtDeferred Compensation Flng OrgDeferredCompensationFlngOrgAmtDeferred Comp Rltd OrgsDeferredCompRltdOrgsAmtNontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmtNontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmtTotal Compensation Filing OrgTotalCompensationFilingOrgAmtTotal Compensation Rltd OrgsTotalCompensationRltdOrgsAmtComp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmtComp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt
KENNETH M FARBER
CEO AND PRESIDENT$372,500$0$50,000$0$6,866$0$28,500$0$52,965$0$510,831$0$0$0
DEBRA ROSE
CHIEF FINANCE OFFICER$189,188$0$30,000$0$1,368$0$24,410$0$22,068$0$267,034$0$0$0
ANDREA O'NEILL
EXECUTIVE DIRECTOR$220,000$0$50,000$0$1,791$0$29,700$0$20,397$0$321,888$0$0$0
ALBERT ROY
EXECUTIVE DIRECTOR, LUCIN$231,790$0$40,000$0$1,406$0$27,179$0$49,679$0$350,054$0$0$0
TEODORA STAEVA
CHIEF SCIENTIFIC OFFICER$258,837$0$40,000$0$1,965$0$22,800$0$40,130$0$363,732$0$0$0
DIANE GROSS
NATIONAL DIRECTOR OF ADVOC$138,424$0$500$0$860$0$15,282$0$27,498$0$182,564$0$0$0
JONATHAN MARKS
DIRECTOR OF CORPORATE DEVE$141,900$0$1,000$0$934$0$15,719$0$33,284$0$192,837$0$0$0
MARGY MEISLIN
EDITORIAL & PR DIRECTOR$128,750$0$1,000$0$3,447$0$14,272$0$26,421$0$173,890$0$0$0
PENELOPE MITCHELL
DIRECTOR OF COMMUNICATIONS$164,800$0$5,000$0$2,380$0$13,192$0$22,593$0$207,965$0$0$0
DOREY NEILINGER
SENIOR DIRECTOR OF PHILANT$164,250$0$5,000$0$3,149$0$18,618$0$16,610$0$207,627$0$0$0

Schedule M IRS990ScheduleM

Securities Publicly Traded SecuritiesPubliclyTradedGrp

FieldValueIRS element (for citing)
Non Cash CheckboxYes (X)NonCashCheckboxInd
Contribution8ContributionCnt
Noncash Contributions Rpt F990$157,755NoncashContributionsRptF990Amt
Method Of Determining RevenuesAVG STOCK VALUEMethodOfDeterminingRevenuesTxt
FieldValueIRS element (for citing)
Any Property That Must Be Held0AnyPropertyThatMustBeHeldInd
Review Process Unusual NC GiftsYes (1)ReviewProcessUnusualNCGiftsInd
Third Parties UsedYes (1)ThirdPartiesUsedInd

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferencePART I, LINE 32B:FormAndLineReferenceDesc
ExplanationLRA HAS AN ACCOUNT WITH MORGAN STANLEY, WHICH LRA USES TO SELL THE CONTRIBUTIONS IT RECEIVES THOUGH STOCKS.ExplanationTxt

Schedule O IRS990ScheduleO

Supplemental Information Detail SupplementalInformationDetail (7 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
FORM 990, PART VI, SECTION A, LINE 2NEIL J. BURMEISTER (DIRECTOR) AND IRA AKSELRAD (DIRECTOR) HAVE A BUSINESS RELATIONSHIP. RICHARD K. DESCHERER (CO-CHAIR) AND JENNIE DESCHERER HAVE A FAMILY RELATIONSHIP.
FORM 990, PART VI, SECTION B, LINE 11BAFTER PREPARATION OF FORM 990 BY LRA'S AUDITOR, LUTZ AND CARR, THE 990 IS REVIEWED BY THE LRA'S SENIOR OFFICERS, THE CHIEF FINANCE OFFICER AND THE PRESIDENT. THE FINANCE AND AUDIT COMMITTEE OF THE BOARD THEN MEETS TO REVIEW THE 990 BEFORE FILING AND APPROVES FOR FILING WITH ANY NOTED CHANGES. A DRAFT OF THE 990 IS THEN SENT OUT TO THE FULL BOARD FOR COMMENT PRIOR TO FILING WITH THE IRS. THE FINAL FORM 990 IS PRESENTED TO THE FULL BOARD AT THE SEPTEMBER MEETING.
FORM 990, PART VI, SECTION B, LINE 12CTHE GOVERNANCE COMMITTEE OF THE BOARD IS RESPONSIBLE FOR MONITORING CONFLICTS OF INTEREST. AN ANNUAL CONFLICT OF INTEREST DISCLOSURE FORM IS REQUIRED TO BE FILLED OUT EACH YEAR BY BOARD MEMBERS, OFFICERS AND KEY EMPLOYEES.
FORM 990, PART VI, SECTION B, LINE 15THE COMPENSATION COMMITTEE OF THE BOARD OF DIRECTORS ASSISTED THE BOARD IN FULFILLING ITS OVERSIGHT RESPONSIBILITIES RELATING TO THE COMPENSATION AND BENEFITS OF THE PRESIDENT AND OTHER EXECUTIVE OFFICERS; AND PROVIDED RECOMMENDATIONS REGARDING MANAGEMENT SUCCESSORS. ANNUALLY THE COMMITTEE REVIEWS AND RECOMMENDS TO THE BOARD THE SALARY FOR THE PRESIDENT AND OTHER OFFICERS/KEY EMPLOYEES. IN 2021, THE COMMITTEE REVIEWED AND APPROVED BASE SALARIES, ANNUAL COST OF LIVING ADJUSTMENTS AND BONUSES FOR ALL STAFF.
FORM 990, PART VI, SECTION C, LINE 19THE ORGANIZATION'S GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY AND FINANCIAL STATEMENTS ARE AVAILABLE UPON REQUEST AND ON GUIDESTAR.ORG
FORM 990, PART XI, LINE 9:REFUND OF GRANTS 28,931. CANCELLED GRANTS 3,613,650.
FORM 990, PART V, QUESTION 2ATHE LRA CONTRACTS WITH TRINET AMBROSE, A PROFESSIONAL EMPLOYER ORGANIZATION (PEO), TO PROVIDE PAYROLL AND BENEFITS AS A CO-EMPLOYER WITH THE LRA. LRA PAYROLL AND BENEFITS ARE ADMINISTERED BY AMBROSE AS APPROVED BY LRA OFFICERS. LRA PAYROLL IS THEREFORE UNDER THE AMBROSE EIN: 13-3867443 AND W-2'S ARE PREPARED UNDER THAT EIN BY TRINET AMBROSE.

Schedule R IRS990ScheduleR

Id Disregarded Entities IdDisregardedEntitiesGrp

Disregarded Entity Name DisregardedEntityName

FieldValueIRS element (for citing)
Business Name Line1LUPUS THERAPEUTICS LLCBusinessNameLine1Txt

US Address USAddress

FieldValueIRS element (for citing)
Address Line1270 MADISON AVENUEAddressLine1Txt
CityNEW YORKCityNm
State AbbreviationNYStateAbbreviationCd
ZIP10016ZIPCd
FieldValueIRS element (for citing)
EIN823984908EIN
Primary ActivitiesLRA'S SCIENTIFIC PROGRAMSPrimaryActivitiesTxt
Legal Domicile StateVALegalDomicileStateCd
Total Income$1,181,046TotalIncomeAmt
End Of Year Assets$14,541,019EndOfYearAssetsAmt

Direct Controlling Entity Name DirectControllingEntityName

FieldValueIRS element (for citing)
Business Name Line1YESBusinessNameLine1Txt